SCHEMBL8942292

SCHEMBL8942292

NC(=O)NCCN(O)C(=O)COc1cccc(Oc2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.54
ALDH1A1 P00352 3/20 0.54
ALOX5 P09917 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.45
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44
LMNA P02545 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
FDFT1 P37268 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 2/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
EPOR P19235 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8942657 0.91 ALOX5 (0.56) KDM4EALDH1A1ALOX5SMN1; SMN2L3MBTL1
SCHEMBL8942625 0.84 ALOX5 (0.47) ALDH1A1ALOX5SMN1; SMN2TDP1MEN1
SCHEMBL8782626 0.83 KDM4E (0.61) KDM4EALDH1A1ALOX5SMN1; SMN2HTR1D
SCHEMBL8942608 0.83 FDFT1 (0.48) ALOX5FDFT1
SCHEMBL8942663 0.79 ALOX5 (0.46) KDM4EALDH1A1ALOX5SMN1; SMN2HTR1D
SCHEMBL8942388 0.78 KDM4E (0.54) KDM4EALDH1A1ALOX5SMN1; SMN2HTR1D
SCHEMBL8942484 0.76 PARP10 (0.50) ALDH1A1ALOX5SMN1; SMN2MEN1KMT2A
SCHEMBL8782786 0.74 CYP1A2 (0.61) KDM4EALDH1A1ALOX5SMN1; SMN2MEN1
SCHEMBL8783294 0.73 MEN1 (0.57) ALDH1A1ALOX5SMN1; SMN2LMNAMEN1
SCHEMBL8942402 0.73 EPOR (0.46) ALOX5LMNAMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514702-A Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity ABBOTT LABORATORIES (US) 1996-05-07 US disclosed